Bio
Dr Gill focuses on all aspects of surgical treatment of urologic malignancies and is experienced in both open and minimally invasive surgery including robotic surgery. He has collaborated with multiple subspecialists and has published on many facets of urologic oncology. Dr Gill’s practice and research also focuses on benign prostatic hyperplasia (BPH) and he offers all minimally invasive therapies for this condition. He is also actively involved in developing and studying new minimally invasive devises for the treatment of BPH.
Clinical Focus
- Cancer > Urologic Oncology
- Bladder Cancer
- Kidney Cancer
- Benign Prostatic Hyperplasia
- Prostate Cancer
- Testicular Tumors
- Ureteral Cancer
- minimially invasive BPH surgery
- Penile Cancer
- Urethral Cancer
- Urologic Cancers
- Laser prostate surgery
- Urology
- Bladder Cancer - Urologic Oncology
- Radical nerve sparing prostatectomy
- robotic prostatectomy
- Radical cystectomy
- Laparoscopic kidney surgery
Administrative Appointments
-
Program Director, Residency program (2006 - Present)
-
Clerkship Director, Urology (1998 - 2005)
Boards, Advisory Committees, Professional Organizations
-
Fellow, Center for innovation in Global Health, Stanford University (2016 - Present)
Professional Education
-
Residency: Royal College of Physician of Ireland (1982) Ireland
-
Internship: Kenyatta National Hosp (1978)
-
Medical Education: University Of Nairobi (1977) Kenya
-
Fellowship: Perelman School of Medicine University of Pennsylvania (1991) PA
-
Board Certification: American Board of Urology, Urology (1995)
-
Residency: Institute Of Urology (1987) England